FiercePharma

FDA Approves Updates to Lilly's Humalog® (insulin lispro injection [rDNA origin]) Label

continuous insulin infusion pump therapy in children 4 years of age and over with type 1 diabetes extension of the time-in-use in the external pump reservoir to a maximum of seven days; and extension ...
Healio

FDA approves larger capacity Humalog insulin pen

The FDA recently approved a 200 units/mL Humalog KwikPen, a pre-filled, rapid-acting insulin pen designed to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company ...
Healio

Humalog Junior insulin pen now available in US

The Humalog Junior KwikPen, a prefilled, rapid-acting insulin pen designed to improve glycemic control in people with type 1 or type 2 diabetes, is now available for prescription in the U.S., Eli ...
Monthly Prescribing Reference

Humalog Junior KwikPen Soon to Be Available

Humalog Junior KwikPen U-100 will be available as 5-count cartons. The BD pen needles are recommended for use with Humalog Junior KwiKPen. The Humalog Junior KwikPen (insulin lispro; Eli Lilly), a ...
FiercePharma

U.S. Food and Drug Administration Approves Humalog® 200 units/mL KwikPen

Marks approval of first concentrated mealtime insulin analog in the U.S. and expands Lilly's portfolio of medicines for people with type 1 and type 2 diabetes INDIANAPOLIS, May 27, 2015 /PRNewswire/ - ...